Safety and Tolerability Study of ST-503 for Refractory Pain Due to Peripheral Neuropathy (Small Fiber Predominant, SFN)
Safety and Tolerability Study of ST-503 for Refractory Pain Due to Peripheral Neuropathy (Small Fiber Predominant, SFN)
Recruiting · NCT06980948 · Registry updated 2026-06-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Tolerability Study of ST-503 for Refractory Pain Due to Peripheral Neuropathy (Small Fiber Predominant, SFN) | Small Fiber Neuropathy, nervous system disorder, neuromuscular disease, peripheral nervous system disorder | Recruiting | Phase 1 / Phase 2 | 2026-06-01 | NCT06980948 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Sangamo Therapeutics | 5 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Columbia University Irving Medical Center (CUIMC) and New York-Presbyterian Hospital (NYPH) | New York | United States | 1 |
| Dartmouth Hitchcock Medical Center | Lebanon | United States | 23 |
| HonorHealth | Scottsdale | United States | 2 |
| Johns Hopkins University | Baltimore | United States | 49 |
| Massachusetts General Hospital | Boston | United States | 1015 |
| The University of California, San Diego | La Jolla | United States | 1 |
| University of Arkansas for Medical Sciences | Little Rock | United States | 218 |
| University of North Carolina Medical Center | Chapel Hill | United States | 16 |
| University of Utah | Salt Lake City | United States | 137 |
| Vanderbilt University | Nashville | United States | 16 |
| Virginia Commonwealth University | Richmond | United States | 25 |